NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public.…Read More
ROSEN NATIONAL TRIAL COUNSEL Encourages Phathom Pharmaceuticals Inc Investors to Inquire About Securities Class Action Investigation PHAT
